staurosporine aglycone has been researched along with Shock, Septic in 1 studies
staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor
Shock, Septic: Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inaba, H | 1 |
| Numai, T | 1 |
| Araki, M | 1 |
| Mizuguchi, T | 1 |
1 other study available for staurosporine aglycone and Shock, Septic
| Article | Year |
|---|---|
K252a, a potent protein kinase inhibitor, improves endotoxic lethality and glucose dyshomeostasis.
Topics: Animals; Blood Glucose; Carbazoles; Endotoxins; Indole Alkaloids; Male; Protein Kinase C; Rats; Rats | 1993 |